Searched for
INDIA PHARMA REVENUE GROWTH
Nykaa expects Q1 revenue growth near 30%, helped by fashion recoveryThe company, in a voluntary quarterly update filed with the stock exchanges on Sunday, said consolidated gross merchandise value and net sa...- El Nino impact in sight even as top FMCG firms bet on rising India consumptionIndia's top retail firms anticipate robust April-June revenue growth, fueled by steady consumer demand and improving rural sentiment. Compa...
- Indian IT firms likely to report muted Q1 growth amid AI spending, macro uncertaintyIndia's Information Technology (IT) companies are expected to report another quarter of subdued earnings growth despite seasonal strength, ...
- FMCG, healthcare in line for strong show in FY27: BrickworksIndia's consumer goods and healthcare sectors are poised for robust growth this fiscal year, driven by tax relief, increasing consumer spen...
- 'Telcos may do well in Q1; tariff hikes likely in H2,' say analystsTelecom operators are poised for single-digit revenue growth this quarter, driven by steady subscriber additions and users opting for premi...
- US, West Asia drag India's pharma exports growthIndian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to W...
- Dabur, Godrej say demand holds firm despite cost pressuresIndian consumer goods giants Dabur and Godrej Consumer Products reported resilient demand in early fiscal 2027, defying geopolitical worrie...
- India's Godrej Consumer expects volume-driven first-quarter revenue riseGodrej Consumer anticipates a robust first quarter, projecting high-teen consolidated revenue growth driven by solid underlying volume incr...
- Food inflation shaped household choices; long-term growth potential intact: Nestle chairmanNestle India's Chairman highlighted how food inflation reshaped consumer choices, impacting pack sizes and purchase habits in FY26. Despite...
- Consumer & healthcare best placed most sectors stable, says BrickworkIndia's consumer goods and healthcare sectors are poised for strong growth this fiscal year, fueled by tax cuts, rising consumer demand, an...
- Swara Baby files DRHP with Sebi for Rs 1,000 crore IPOSwara Baby has filed its DRHP with Sebi for a Rs 1,000 crore IPO, comprising a Rs 500 crore fresh issue and Rs 500 crore OFS. The hygiene p...
- June GST collections 13.9% to ₹1.95 lakh croreIndia's GST revenue surged 13.9% to ₹1.95 lakh crore in June, driven by a significant 34.6% jump in import tax collections. While domestic ...
- Delayed monsoon may weigh on auto demand, but long-term outlook stays strong: Aditya ShahA delayed monsoon poses a temporary challenge to rural auto demand, particularly for tractors and two-wheelers, but the sector's long-term ...
- PayU India posts first full-year operating profit in FY26; revenue rises 13%During the second half of FY26, PayU India also exited certain "negative margin portfolios", impacting its sequential revenue growth. In th...
- Auto ancillary sector revenue grew 12.5% in FY26 on volume gains and improved product mix: ReportIndian auto ancillaries witnessed robust revenue growth of 12.5% in FY26, driven by strong volumes and a better product mix. While EBITDA a...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
Load More
